NIAID has a new funding opportunity “Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)”.
For any questions, applicants are strongly encouraged to contact Katrin Eichelberg prior to the deadline June 30th, 2021.
International applicants are eligible to apply.